Manjishtha (Rubia cordifolia) ↔ Modern Anthraquinone Genotoxicity & Antitumour Peptide Research

Manjishtha is Ayurveda's first blood-purifying and complexion drug, but its genus includes lucidin, an anthraquinone genotoxic enough that European regulators withdrew Rubia tinctorum from medicinal use — alongside a harmless but alarming red-orange urine discolouration, and a genuinely interesting antitumour peptide research angle.

IN PLAIN LANGUAGE

Manjishtha is Ayurveda's classic blood-purifying and skin-brightening herb, and it can turn your urine a harmless red or orange colour that looks alarming but usually isn't; a closely related plant was pulled from use in Europe over cancer-risk concerns with one of its compounds, which is why it isn't a good idea to use Manjishtha continuously long-term without medical input.

Ayurveda offers a well-established traditional blood-purifying and complexion remedy; modern toxicology offers the genotoxicity testing that has already flagged a real risk in a closely related plant, and cancer research is separately exploring genuinely promising antitumour compounds from the same genus.

WHEN TO SEEK CARE

Tell your doctor before assuming red or orange urine is just from Manjishtha — it needs a simple urine test to rule out actual bleeding, and see a doctor before continuous long-term use given unresolved safety questions about this plant family.

🔴 REFER IMMEDIATELY

Long-term or high-dose continuous use of Manjishtha preparations without periodic safety review, given the genus's genotoxicity history
Red or orange urine mistaken for haematuria, leading to unnecessary alarm, or conversely true haematuria dismissed as a harmless Manjishtha effect
Use in pregnancy or in a patient with known hepatic impairment, pending clearer genotoxicity data for this species
Any blood actually visible in urine, as opposed to red/orange discolouration, needs proper urinalysis to distinguish it from pigmenturia
Suspected adverse reaction or unexplained symptoms during long-term Manjishtha use

Never do this

Do not assume any red or orange-tinted urine during Manjishtha use is automatically harmless without first confirming it is not true haematuria, and do not continue indefinite high-dose use without safety review given the genus's genotoxicity history.

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

Short-to-moderate-course Manjishtha use for raktashodhana/varnya indications in a patient counselled about the harmless urine colour change, pending further species-specific safety data for long-term use.

MODERN MEDICINE SCOPE

Genotoxicity/mutagenicity assessment of herbal anthraquinone sources, and urinalysis to distinguish pigmenturia from true haematuria.

COLLABORATIVE SCOPE

Patients on Manjishtha should be told in advance that urine may turn red or orange, so it is not mistaken for bleeding, and long-term continuous use should be reviewed given the unresolved genus-level genotoxicity question.

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.